CARE Ratings Ltd Gains 8.94%: 5 Key Factors Driving the Rally

11 May 2026: Market Weakness Hits Stock Early in the Week

CARE Ratings Ltd opened the week at Rs.1,602.10, down 3.11% from the previous close, reflecting a broad market sell-off as the Sensex declined 1.40% to 35,679.54. The stock’s volume was moderate at 5,644 shares, indicating cautious investor sentiment amid sector-wide pressures. This initial weakness set a challenging tone for the week, with the stock underperforming the market on the first trading day.

12 May 2026: Continued Downtrend Amid Broader Market Decline

The downward momentum persisted on 12 May, with CARE Ratings slipping further by 1.09% to Rs.1,584.65. The Sensex also suffered a sharper decline of 2.19%, closing at 34,899.09. The stock’s volume dropped to 1,979 shares, suggesting reduced trading activity as investors awaited clearer signals. Despite the decline, the stock’s relative performance was marginally better than the Sensex, which fell more steeply.

13 May 2026: Early Signs of Recovery with Modest Gains

On 13 May, CARE Ratings began to recover, gaining 1.39% to close at Rs.1,606.60. This rebound coincided with a modest 0.32% rise in the Sensex to 35,010.26. The stock’s volume was relatively low at 1,178 shares, indicating a tentative return of buying interest. This day marked the start of a positive momentum shift that would accelerate in the following sessions.

14 May 2026: Breakout Day with Gap Up and Intraday High

CARE Ratings Ltd delivered a standout performance on 14 May, opening with a significant gap up of 5.5% and closing at Rs.1,736.75, an 8.10% gain on the day. The stock reached an intraday high of Rs.1,787.10, marking an 11.23% increase from the previous close. This surge was accompanied by a substantial volume spike to 27,876 shares, signalling strong buying interest. The stock outperformed the Capital Markets sector, which rose 2.27%, and the Sensex, which gained a modest 1.01%.

This rally was supported by CARE Ratings’ strong quarterly results, reporting a 28.77% year-on-year increase in Profit Before Tax excluding other income to ₹56.30 crores, and a 24.0% rise in net profit after tax to ₹52.83 crores. The company’s net-debt-free status and high institutional shareholding of 54.63% further reinforced investor confidence.

Technical indicators showed the stock trading above all key moving averages (5-day to 200-day), with a bullish weekly MACD and mildly bullish Bollinger Bands, although some short-term bearish signals persisted. The stock’s high beta of 1.35 relative to the NIFTY MIDCAP150 index explained the pronounced price swings during this session.

15 May 2026: Technical Momentum Shift and Continued Gains

On 15 May, CARE Ratings confirmed a technical momentum shift, closing at Rs.1,801.35, up 3.72% from the previous day. The stock traded within a range of Rs.1,695.00 to Rs.1,787.10, inching closer to its 52-week high of Rs.1,964.80. Volume moderated to 9,431 shares, reflecting sustained but more measured buying interest.

The technical trend transitioned from mildly bearish to sideways, supported by a bullish weekly MACD and Bollinger Bands, though the weekly RSI remained bearish and daily moving averages mildly bearish. On-Balance Volume was mildly bullish weekly, indicating volume support for the price rally. The company’s Mojo Score improved to 54.0 with an upgraded Mojo Grade of Hold, reflecting improved technical and fundamental outlooks.

MarketsMOJO’s upgrade from Sell to Hold on 14 May was driven by the strong quarterly earnings, stabilising technical indicators, and consistent long-term returns. Despite a premium valuation with a Price to Book ratio of 6 and a PEG ratio of 1.3, CARE Ratings’ steady profit growth and net sales expansion justify cautious optimism.

Weekly Price Performance: CARE Ratings vs Sensex

Key Takeaways

Strong Weekly Outperformance: CARE Ratings Ltd surged 8.94% over the week, vastly outperforming the Sensex’s 2.63% decline, highlighting robust stock-specific momentum amid a challenging market backdrop.

Robust Earnings and Financial Health: The company’s Q4 FY26 results showed a 28.77% rise in PBT (excluding other income) and a 24.0% increase in net profit, supported by a net-debt-free balance sheet and high institutional ownership.

Technical Momentum Shift: The stock’s technical trend improved from mildly bearish to sideways, with bullish weekly MACD and Bollinger Bands, though some short-term bearish signals remain, suggesting cautious optimism.

Valuation Premium: Despite strong fundamentals, the stock trades at a high Price to Book ratio of 6 and a PEG of 1.3, indicating a premium valuation that warrants careful monitoring.

High Beta and Volatility: CARE Ratings’ beta of 1.35 relative to the NIFTY MIDCAP150 index explains the pronounced price swings, underscoring the stock’s sensitivity to market catalysts and technical developments.

Conclusion

CARE Ratings Ltd’s week was characterised by a significant price rally driven by strong quarterly earnings, a technical momentum shift, and an upgrade in analyst ratings. The stock’s ability to outperform the Sensex by over 11 percentage points amid a broadly weak market underscores its relative strength and resilience. While the premium valuation and mixed technical signals counsel prudence, the company’s consistent profit growth, net-debt-free status, and high institutional backing provide a solid foundation. Investors should monitor ongoing technical developments and valuation metrics closely as the stock consolidates its recent gains.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →